KOR-1 Antibodies

Santa Cruz Biotechnology offers a broad range of KOR-1 monoclonal antibodies for investigating the kappa-opioid receptor (KOR-1) in various biological processes. KOR-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KOR-1 plays a critical role in modulating pain, stress responses, and addiction pathways, making it an important target for therapeutic interventions. The involvement of KOR-1 in the central nervous system highlights its significance in neuropharmacology and the development of pain management strategies. Research focused on KOR-1 can provide insights into the mechanisms of opioid action and the potential for new treatments for opioid-related disorders. KOR-1 monoclonal antibodies enable precise detection and characterization of KOR-1 expression patterns across different tissues and experimental conditions. Studying KOR-1 distribution and regulation contributes to understanding its role in neural circuits and behavior. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of opioid receptor biology and potential therapeutic applications.